PARIS, June 11, 2025 (GLOBE NEWSWIRE) -- NVIDIA GTC Paris at VivaTech — NVIDIA today announced a collaboration with Novo Nordisk to accelerate drug discovery efforts through innovative AI use cases.

Novo Nordisk and tech giant NVIDIA have joined forces on a new project that aims to speed up drug discovery using generative AI. Skip to main content Friday 18 July 2025 . BlueSky linkedin ...

June 11 - Novo Nordisk (NYSE:NVO) has teamed up with Nvidia (NASDAQ:NVDA) to integrate artificial intelligence into its drug development pipeline, aiming to speed up early-stage research ...

PARIS - Nvidia (NASDAQ:NVDA), the semiconductor giant with an excellent financial health score according to InvestingPro, announced today a collaboration with Novo Nordisk to accelerate drug discovery ...

Nvidia (NVDA, Financials) said Tuesday it is partnering with Novo Nordisk to accelerate drug discovery using its generative and agentic AI tools.Warning! GuruFocus has detected 4 Warning Signs ...

Pharmaceutical giant Novo Nordisk (NVO) plans to use Denmark's first sovereign artificial intelligence (AI) supercomputer—powered by Nvidia (NVDA) technology—for drug discovery. On Wednesday ...

The Novo Nordisk Foundation plans to build a supercomputer in Denmark made up of an Nvidia DGX SuperPOD. The system will be used for both AI and quantum computing research for medical applications.

Denmark unveiled an Nvidia-powered supercomputer that will be used by researchers from Novo Nordisk A/S and other Danish pharmaceutical companies as they seek novel drugs and smarter trial designs.

Certain statements in this press release including, but not limited to, statements as to: working with Novo Nordisk, NVIDIA advancing critical R&D applications with fundamental tools that can ...